X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Indian share markets trade strong 
(Fri, 7 Mar 01:30 pm) 
 
Indian share markets continued to trade at high levels in the post-noon trading session. Majority of the sectoral indices are trading in the green with realty, banking and capital goods stocks being the biggest gainers. However, IT, pharma and consumer durable are among the few stocks trading in the red.

BSE-Sensex is up 319 points and NSE-Nifty is trading 100 points up. BSE Mid Cap and BSE Small Cap indices are trading marginally down. The rupee is trading at 61.0 to the US dollar.

Most of the domestic pharma stocks are trading in the red with Dr. Reddy's Lab and Ipca Labs being the major losers whereas Orchid Chemicals and Fresnius Kabi are a few stocks trading in the green. As per a leading financial daily, Lupin has won approval from US Food & Drug Administration (USFDA) to market generic version of Bayer's Cipro in the US market. The final approval is for oral suspension of Ciprofloxacin in 250 mg/ml and 500 mg/ml that is used in the treatment of infections. Being the first company to file an abbreviated new drug application (ANDA) for Cipro oral suspension, the company is also entitled to 180-days of marketing exclusivity. Lupin's US subsidiary would commence marketing the products shortly. Additionally, the company has also received USFDA approval to market generic version of Aqua Pharmaceuticals' Monodox capsules also used in the treatment of infections. As per IMS sales data, 2013 US sales of Monodox capsules stood at $180.6 m whereas that for Cipro Oral suspension was $ 8.6 m. Lupin's stock is trading down 2.7%.

Majority of the large software stocks are trading in the red today with Wipro and Tech Mahindra leading among losers. As per a leading business daily, TCS is likely to manage some part of the IT services business of Thomson Reuters. Both the companies have reached an agreement under which Thomson Reuters would outsource a portion of its information technology services. Thomson Reuters is a global news and information dissemination company. The company is planning ways to trim down its costs and build efficiencies in operations as its bank clients in Europe and Asia are cutting on their spending. As a part of the move to disseminate its IT services work to the software giant, it is believed that Reuters will shift 400 of its back office employees in Bangalore to TCS's office. TCS is trading down 1.7% today.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Indian share markets trade strong". Click here!

  
 

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Sep 20, 2017 (Close)

S&P BSE HEALTHCARE 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS